Adjuvant chemotherapy of osteogenic sarcoma: progress and perspectives.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002452:Cell Count; D002470:Cell Survival / Q000187:drug effects; D002648:Child; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007700:Kinetics; D002955:Leucovorin / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000628:therapy; D012516:Osteosarcoma / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy
D000970:Antineoplastic Agents; D002955:Leucovorin; D008727:Methotrexate